Calithera Biosciences’ CB-280 Arginase Inhibitor Trial in Progress Poster Presented at the North American Cystic Fibrosis 2020 Virtual Conference October 7, 2020 - NASDAQ Companies 0 Bay Street News » View More News for October 07, 2020
